Literature DB >> 27324237

Immunology of hepatic diseases during pregnancy.

Lars Bremer1, Christoph Schramm2, Gisa Tiegs3,4.   

Abstract

The mother's immune system has to adapt to pregnancy accepting the semi-allograft fetus and preventing harmful effects to the developing child. Aberrations in feto-maternal immune adaptation may result in disease of the mother, such as liver injury. Five pregnancy-associated liver disorders have been described so far, however, little is known concerning immune alterations promoting the respective disease. These liver disorders are pre-eclampsia, hemolysis, elevated liver enzymes, low platelet count (HELLP), acute fatty liver, hyperemesis gravidarum, and intrahepatic cholestasis of pregnancy. On the other hand, pre-existing autoimmune liver injury of the mother can be affected by pregnancy. This review intends to summarize current knowledge linking feto-maternal immunology and liver inflammation with a special emphasis on novel potential biomarkers.

Entities:  

Keywords:  Acute fatty liver of pregnancy; Auto immune hepatitis; HELLP; Hyperemesis gravidarum; Intrahepatic cholestasis of pregnancy; Pre-eclampsia; Pregnancy

Mesh:

Substances:

Year:  2016        PMID: 27324237     DOI: 10.1007/s00281-016-0573-1

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  216 in total

1.  The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients.

Authors:  F Reister; H G Frank; W Heyl; G Kosanke; B Huppertz; W Schröder; P Kaufmann; W Rath
Journal:  Placenta       Date:  1999 Mar-Apr       Impact factor: 3.481

2.  How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis?

Authors:  A Goel; B Ramakrishna; U Zachariah; J Ramachandran; C E Eapen; G Kurian; G Chandy
Journal:  Gut       Date:  2010-10-11       Impact factor: 23.059

3.  Incidence of preeclampsia in pregnant Swiss women.

Authors:  Mette-Triin Purde; Marc Baumann; Ute Wiedemann; Urs E Nydegger; Lorenz Risch; Daniel Surbek; Martin Risch
Journal:  Swiss Med Wkly       Date:  2015-07-28       Impact factor: 2.193

4.  Maternal and fetal serum levels of caspase-cleaved fragments of cytokeratin-18 in intrahepatic cholestasis of pregnancy.

Authors:  Ali Ozgur Ersoy; Ayse Kirbas; Sibel Ozler; Ebru Ersoy; A Seval Ozgu-Erdinc; Merve Ergin; Salim Erkaya; Dilek Uygur; Nuri Danisman
Journal:  J Matern Fetal Neonatal Med       Date:  2015-02-10

5.  Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.

Authors:  Espen Melum; Andre Franke; Christoph Schramm; Tobias J Weismüller; Daniel Nils Gotthardt; Felix A Offner; Brian D Juran; Jon K Laerdahl; Verena Labi; Einar Björnsson; Rinse K Weersma; Liesbet Henckaerts; Andreas Teufel; Christian Rust; Eva Ellinghaus; Tobias Balschun; Kirsten Muri Boberg; David Ellinghaus; Annika Bergquist; Peter Sauer; Euijung Ryu; Johannes Roksund Hov; Jochen Wedemeyer; Björn Lindkvist; Michael Wittig; Robert J Porte; Kristian Holm; Christian Gieger; H-Erich Wichmann; Pieter Stokkers; Cyriel Y Ponsioen; Heiko Runz; Adolf Stiehl; Cisca Wijmenga; Martina Sterneck; Severine Vermeire; Ulrich Beuers; Andreas Villunger; Erik Schrumpf; Konstantinos N Lazaridis; Michael P Manns; Stefan Schreiber; Tom H Karlsen
Journal:  Nat Genet       Date:  2010-12-12       Impact factor: 38.330

6.  The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth.

Authors:  Marcus G Martineau; Christina Raker; Peter H Dixon; Jenny Chambers; Mavis Machirori; Nicole M King; Melissa L Hooks; Ramya Manoharan; Kenneth Chen; Raymond Powrie; Catherine Williamson
Journal:  Diabetes Care       Date:  2014-12-12       Impact factor: 19.112

7.  Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.

Authors:  P H Dixon; N Weerasekera; K J Linton; O Donaldson; J Chambers; E Egginton; J Weaver; C Nelson-Piercy; M de Swiet; G Warnes; E Elias; C F Higgins; D G Johnston; M I McCarthy; C Williamson
Journal:  Hum Mol Genet       Date:  2000-05-01       Impact factor: 6.150

8.  Prenatal acetaminophen affects maternal immune and endocrine adaptation to pregnancy, induces placental damage, and impairs fetal development in mice.

Authors:  Kristin Thiele; M Emilia Solano; Samuel Huber; Richard A Flavell; Timo Kessler; Roja Barikbin; Roman Jung; Khalil Karimi; Gisa Tiegs; Petra C Arck
Journal:  Am J Pathol       Date:  2015-08-05       Impact factor: 4.307

9.  Androgens and hyperemesis gravidarum: a case-control study.

Authors:  Ragnhild Helseth; Merethe Ravlo; Sven M Carlsen; E Eszter Vanky
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2014-01-14       Impact factor: 2.435

10.  Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity.

Authors:  Chris Gardiner; Dionne S Tannetta; Carol A Simms; Paul Harrison; Christopher W G Redman; Ian L Sargent
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

View more
  3 in total

1.  Beyond the "take-home baby": pregnancy as a modulator of organ-specific immunity in mother and offspring.

Authors:  Petra Clara Arck
Journal:  Semin Immunopathol       Date:  2016-10-10       Impact factor: 9.623

2.  Effect of Nanoherbal Andaliman (Zanthoxylum acanthopodium) and Extra Virgin Olive Oil Combination on Preeclamptic Rats Liver Histology.

Authors:  Putri Cahaya Situmorang; Syafruddin Ilyas; Salomo Hutahaean; Rosidah Rosidah
Journal:  Open Access Maced J Med Sci       Date:  2019-07-14

Review 3.  The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?

Authors:  Lara Henze; Dorothee Schwinge; Christoph Schramm
Journal:  Front Immunol       Date:  2020-07-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.